Clinical services company SpecialtyCare announced today that chairman and CEO Mike Mauldin has stepped down and that Melvin Hall has been appointed CEO.
Mauldin joined SpecialtyCare in 2010 as CFO and also served as COO before becoming CEO in August 2012 after the death of founder and CEO Gary Brukardt. Under Mauldin's leadership, the Nashville-based company acquired and integrated several providers, including NeuroMatrix, CETECH and Advanced Perfusion Care.
"Mike has dedicated himself to expanding our clinical and operational framework, helping us integrate several important acquisitions and strengthening our key value propositions," Marc Saiontz, managing director at SpecialtyCare's lead investor American Securities, said in a release.
Hall, Mauldin's successor, previously served as president and CEO of Press Ganey Associates, leading the implementation of the Hospital Consumer Assessment of Healthcare Providers and Systems. He then served as chairman of Press Ganey's board and as a senior health policy advisor to Dentons. Hall has served on SpecialtyCare's board of directors since 2011.
"[Hall] is an experienced CEO who understands the health care industry and has demonstrated remarkable talent for creating efficient environments and strong organizational cultures," Saiontz said. "That combination will help identify and drive exciting new opportunities. We look forward to growing SpecialityCare's critical and market-leading position under his new leadership."
POSTDATA: WARRANTY DEEDS